SV2A in Older Adults

Recruiting Phase 1 Phase 2 Interventional Study
Cannabis Use
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Other
Participants needed
24 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Able to provide informed consent * Male or female, aged ≥50 years * No history of significant medical or neurological disease * BMI ≤ 50 * If woman of childbearing potential, must agree to use an acceptable method of birth control, as determined by the principal investigator, …
Contacts

Angerlyk Frytz, MD

203-974-7822

angerlyk.frytz@yale.edu

CONTACT